Preview: OptimizeRx's Earnings

OptimizeRx OPRX will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate OptimizeRx to report an earnings per share (EPS) of $0.06.

Anticipation surrounds OptimizeRx's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

During the last quarter, the company reported an EPS beat by $0.08, leading to a 5.31% drop in the share price on the subsequent day.

Here's a look at OptimizeRx's past performance and the resulting price change:

Tracking OptimizeRx's Stock Performance

Shares of OptimizeRx were trading at $6.06 as of November 11. Over the last 52-week period, shares are down 39.52%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for OptimizeRx visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.